International consensus statement on allergy and rhinology: rhinosinusitis 2021

Guías clínicas

Tipo de documento

DOI

DOI: 10.1002/alr.22741.
Autores
Richard R Orlandi 1, Todd T Kingdom 2, Timothy L Smith 3, Benjamin Bleier 4, Adam DeConde 5, Amber U Luong 6, David M Poetker 7, Zachary Soler 8, Kevin C Welch 9, Sarah K Wise 10, Nithin Adappa 11, Jeremiah A Alt 1, Wilma Terezinha Anselmo-Lima 12, Claus Bachert 13 14 15, Fuad M Baroody 16, Pete S Batra 17, Manuel Bernal-Sprekelsen 18, Daniel Beswick 19, Neil Bhattacharyya 4, Rakesh K Chandra 20, Eugene H Chang 21, Alexander Chiu 22, Naweed Chowdhury 23, Martin J Citardi 6, Noam A Cohen 11, David B Conley 24, John DelGaudio 10, Martin Desrosiers 25, Richard Douglas 26, Jean Anderson Eloy 27, Wytske J Fokkens 28, Stacey T Gray 4, David A Gudis 29, Daniel L Hamilos 30, Joseph K Han 31, Richard Harvey 32, Peter Hellings 33, Eric H Holbrook 4, Claire Hopkins 34, Peter Hwang 35, Amin R Javer 36, Rong-San Jiang 37, David Kennedy 11, Robert Kern 24, Tanya Laidlaw 4, Devyani Lal 38, Andrew Lane 39, Heung-Man Lee 40, Jivianne T Lee 19, Joshua M Levy 10, Sandra Y Lin 39, Valerie Lund 41, Kevin C McMains 42, Ralph Metson 4, Joaquim Mullol 43, Robert Naclerio 39, Gretchen Oakley 1, Nobuyoshi Otori 44, James N Palmer 11, Sanjay R Parikh 45, Desiderio Passali 46, Zara Patel 35, Anju Peters 24, Carl Philpott 47, Alkis J Psaltis 48, Vijay R Ramakrishnan 2, Murugappan Ramanathan Jr 39, Hwan-Jung Roh 49, Luke Rudmik 50, Raymond Sacks 51, Rodney J Schlosser 8, Ahmad R Sedaghat 52, Brent A Senior 53, Raj Sindwani 54, Kristine Smith 55, Kornkiat Snidvongs 56, Michael Stewart 57, Jeffrey D Suh 19, Bruce K Tan 24, Justin H Turner 23, Cornelis M van Drunen 58, Richard Voegels 59, De Yun Wang 60, Bradford A Woodworth 61, Peter-John Wormald 48, Erin D Wright 62, Carol Yan 63, Luo Zhang 64, Bing Zhou 64
Índice

Executive summary: BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document.

Methods: ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary.

Results: ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided.

Conclusion: This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.

Keywords: acute rhinosinusitis; chronic rhinosinusitis; endoscopic sinus surgery; evidence-based medicine; recurrent acute rhinosinusitis; rhinosinusitis; systematic review.